Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Diabetes: Management and Pharmacotherapy

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

Diabetes: Symptoms, Diagnosis, and Complications

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...

Diabetes Mellitus: Overview and Type I Subtype

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...

Kidney Transplant III: Nursing Management

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...

Diabetes Mellitus: Type 2 and Gestational

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

In-person and Telephonic Shared Decision-making Visits for People Considering Lung Cancer Screening: An Assessment of Decision Quality.

Chest·2019

Same author

Differential Impact of Homelessness on Glycemic Control in Veterans with Type 2 Diabetes Mellitus.

Journal of general internal medicine·2016

Same author

Reviewing Human Subjects Research: Efficiency and Quality for the Military and Beyond.

The American journal of bioethics : AJOB·2016

Same author

Real-time monitoring of tumor progression and drug responses in a preclinical mouse model of prostate cancer.

Oncotarget·2016

Same author

CEST-MRI detects metabolite levels altered by breast cancer cell aggressiveness and chemotherapy response.

NMR in biomedicine·2016

Same author

Disturbance characteristics of half-selected cells in a cross-point resistive switching memory array.

Nanotechnology·2016

Search research articles

Related Experiment Videos

Group visits: promoting adherence to diabetes guidelines.

Dawn E Clancy¹, Peng Huang, Eni Okonofua

¹Department of Medicine, Medical University of South Carolina, Charleston, SC 250591, USA. clancyd@musc.edu

Journal of General Internal Medicine

|April 20, 2007

Summary

Group visits improved quality of care for type 2 diabetes patients, increasing adherence to American Diabetes Association guidelines and cancer screenings. However, clinical outcomes like HbA1c, blood pressure, and lipids did not significantly change.

Related Experiment Videos

Area of Science:

Endocrinology
Preventive Medicine
Health Services Research

Background:

Type 2 diabetes management is challenging in disadvantaged populations, despite existing guidelines.
Group visits offer a promising, efficient, and educational care model for chronic disease management.
This modality allows for longer, more frequent, and organized patient-physician interactions.

Purpose of the Study:

To assess the impact of group visits on clinical outcomes in type 2 diabetes patients.
To evaluate adherence to American Diabetes Association (ADA) guidelines and United States Preventive Services Task Force (USPSTF) cancer screenings.
To compare group visit care with traditional patient-physician dyad care.

Main Methods:

A 12-month randomized controlled trial involving 186 patients with type 2 diabetes.
Comparison between care delivered via group visits and traditional one-on-one physician visits.
Assessment of clinical outcomes (HbA1c, blood pressure, lipids) at 6 and 12 months, and quality of care measures at 12 months.

Main Results:

No significant differences in HbA1c, blood pressure, or lipid profiles between group visit and usual care patients at 6 or 12 months.
Group visit patients showed significantly greater concordance with ADA process-of-care indicators (p < .0001) at 12 months.
Higher cancer screening rates were observed in group visit patients for breast (80% vs. 68%, p = .006) and cervical cancers (80% vs. 68%, p = .019).

Conclusions:

Group visits can enhance the quality of care for patients with type 2 diabetes.
Improvements in clinical outcomes may require modifications to the content and delivery style of group visits.
The study highlights the potential of group visits for improving preventive care and guideline adherence.